Literature DB >> 18190237

Gp96 and its different expression in breast carcinomas.

I Hodorova1, S Rybarova, P Solar, J Vecanova, L Prokopcakova, P Bohus, Z Solarova, Y Mellova, K Schmidtova.   

Abstract

The aim of our work was to determine the expression of glycoprotein 96 (gp96; glucose-regulated protein 94 - GRP94) in 69 samples of breast carcinoma. Enzyme immunohistochemical method was chosen for the detection of gp96 protein and its expression was compared in breast cancer cells versus normal breast cells. We found higher expression of gp96 protein in breast carcinoma cells and low or no expression in normal breast cells. Furthermore, we demonstrate first time, that ductal invasive breast carcinomas showed higher expression of gp96 than lobular invasive breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190237

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  4 in total

1.  Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.

Authors:  Po-Li Wei; Chien-Yu Huang; Cheng-Jeng Tai; Uyanga Batzorig; Wan-Li Cheng; Ming-Te Hunag; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2015-12-30

2.  α7 helix region of αI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis.

Authors:  Feng Hong; Bei Liu; Gabriela Chiosis; Daniel T Gewirth; Zihai Li
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

3.  Differential requirement of GRP94 and GRP78 in mammary gland development.

Authors:  Genyuan Zhu; Miao Wang; Benjamin Spike; Peter C Gray; Jieli Shen; Sung-Hyung Lee; Si-Yi Chen; Amy S Lee
Journal:  Sci Rep       Date:  2014-06-23       Impact factor: 4.379

4.  GM2-GM3 gangliosides ratio is dependent on GRP94 through down-regulation of GM2-AP cofactor in brain metastasis cells.

Authors:  Carmen Bedia; Miriam Badia; Laia Muixí; Thierry Levade; Romà Tauler; Angels Sierra
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.